These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 9590318

  • 1. Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines.
    Freeman BD, Zeni F, Banks SM, Eichacker PQ, Bacher JD, Garvey EP, Tuttle JV, Jurgensen CH, Natanson C, Danner RL.
    Crit Care Med; 1998 May; 26(5):877-86. PubMed ID: 9590318
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep.
    Booke M, Hinder F, McGuire R, Traber LD, Traber DL.
    Crit Care Med; 1996 May; 24(5):835-44. PubMed ID: 8706462
    [Abstract] [Full Text] [Related]

  • 3. N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis.
    Strand OA, Leone AM, Giercksky KE, Skovlund E, Kirkebøen KA.
    Crit Care Med; 1998 Sep; 26(9):1490-9. PubMed ID: 9751584
    [Abstract] [Full Text] [Related]

  • 4. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
    Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P.
    Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
    [Abstract] [Full Text] [Related]

  • 5. Cerebral blood flow is not altered in sheep with Pseudomonas aeruginosa sepsis treated with norepinephrine or nitric oxide synthase inhibition.
    Takala J, Booke M, Westphal M, Hinder F, Traber LD, Traber DL.
    Anesth Analg; 2003 Apr; 96(4):1122-1128. PubMed ID: 12651671
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation.
    Statman R, Cheng W, Cunningham JN, Henderson JL, Damiani P, Siconolfi A, Rogers D, Horovitz JH.
    J Surg Res; 1994 Jul; 57(1):93-8. PubMed ID: 8041156
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogs.
    Sevransky J, Vandivier RW, Gerstenberger E, Correa R, Ferantz V, Banks SM, Danner RL, Eichacker PQ, Natanson C.
    Shock; 2005 Mar; 23(3):281-8. PubMed ID: 15718929
    [Abstract] [Full Text] [Related]

  • 8. Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88.
    Harrison RW, Thakkar RN, Senzaki H, Ekelund UE, Cho E, Kass DA, Hare JM.
    Crit Care Med; 2000 May; 28(5):1263-8. PubMed ID: 10834663
    [Abstract] [Full Text] [Related]

  • 9. Norepinephrine and N(G)-monomethyl-L-arginine in hyperdynamic septic shock in pigs: effects on intestinal oxygen exchange and energy balance.
    Träger K, Radermacher P, Rieger KM, Grover R, Vlatten A, Iber T, Adler J, Georgieff M, Santak B.
    Crit Care Med; 2000 Jun; 28(6):2007-14. PubMed ID: 10890656
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of nitric oxide synthase modulation on porcine systemic and pulmonary circulation in vivo.
    Dahm P, Thörne J, Zoucas E, Mårtensson L, Myhre E, Blomquist S.
    Crit Care Med; 1997 Feb; 25(2):280-5. PubMed ID: 9034265
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX, Mensik C, Krishnaswami S, Derendorf H, Eichler HG, Schmetterer L, Wolzt M.
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [Abstract] [Full Text] [Related]

  • 13. Prolonged inhibition of nitric oxide synthesis in severe septic shock: a clinical study.
    Avontuur JA, Tutein Nolthenius RP, van Bodegom JW, Bruining HA.
    Crit Care Med; 1998 Apr; 26(4):660-7. PubMed ID: 9559602
    [Abstract] [Full Text] [Related]

  • 14. Expert opinion on tilarginine in the treatment of shock.
    Howes LG, Brillante DG.
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1573-80. PubMed ID: 18808317
    [Abstract] [Full Text] [Related]

  • 15. Effects of nitric oxide synthase inhibition combined with nitric oxide inhalation in a porcine model of endotoxin shock.
    Klemm P, Thiemermann C, Winklmaier G, Martorana PA, Henning R.
    Br J Pharmacol; 1995 Jan; 114(2):363-8. PubMed ID: 7533615
    [Abstract] [Full Text] [Related]

  • 16. The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia.
    Henderson JL, Statman R, Cunningham JN, Cheng W, Damiani P, Siconolfi A, Horovitz JH.
    Arch Surg; 1994 Dec; 129(12):1271-4; discussion 1275. PubMed ID: 7527209
    [Abstract] [Full Text] [Related]

  • 17. Postsynaptic α1-Adrenergic Vasoconstriction Is Impaired in Young Patients With Vasovagal Syncope and Is Corrected by Nitric Oxide Synthase Inhibition.
    Stewart JM, Suggs M, Merchant S, Sutton R, Terilli C, Visintainer P, Medow MS.
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27444639
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.